COVID-19 vaccination: Vaccination coverage:

  • Last updated: 2023-09-15

Number and percentage of people that have received a COVID-19 vaccine in Canada by province or territory, vaccination status, sex, age group, and last booster dose by vaccine.

Older versions of this report are available on the archived reports page.

Changes to data reporting

We no longer report the number and percentage of people who completed their primary series or received a booster dose in the last 6 months. This aligns with the recent NACI statement about new formulations of COVID-19 vaccines.

Information on the number and percentage of people who have received a COVID-19 vaccine in Canada by province or territory, vaccination status, sex, age group, and last booster dose by vaccine.

We update this information every 12 weeks on Fridays at noon ET, with data up to and including the previous Sunday.

This report was last updated on with data up to and including MMM DD, YYYY.

On this page

Key updates

At least 1 dose

Total population

()

5 years and older

()

0 to 4 years

()
Primary series completed

Total population

()

5 years and older

()

0 to 4 years

()

About COVID-19 vaccination and approved vaccines

About COVID-19 vaccination and approved vaccines

Vaccination programs

  • COVID-19 vaccination began in Canada on December 14, 2020.
  • You’re currently eligible for COVID-19 vaccination if you’re 6 months of age or older and you don’t have contraindications to the vaccine.
  • The National Advisory Committee on Immunization (NACI) issues statements with recommendations on the use of COVID-19 vaccines. Briefly, NACI recommends:
    • a complete primary vaccine series to provide protection against COVID-19
    • booster doses after completing the primary series to restore or improve protection against COVID-19. Please refer to the COVID-19 vaccine chapter of the Canadian Immunization Guide for more details on:
      • booster eligibility
      • timing of a booster dose
      • recommended products
  • On July 11, 2023, NACI released the Guidance on the use of COVID-19 vaccines in the fall of 2023. Currently:
    • NACI recommends a dose of the new formulation of COVID-19 vaccine for anyone in the authorized age groups who:
      • has previously received a COVID-19 vaccine, and
      • hasn’t had a COVID-19 vaccine dose or a COVID-19 infection in the last 6 months
    • Vaccination is particularly important for those at higher risk of COVID-19 infection or severe disease, including people who:
      • are 65 years of age or older
      • live in long-term care homes or other congregate living settings
      • have underlying medical conditions that put them at higher risk of severe COVID-19
      • are pregnant
      • are Indigenous
      • are members of racialized and other equity-deserving communities
      • provide essential community services

Approved vaccines

Vaccines authorized for use for primary vaccine series in Canada currently include:

3-dose vaccines

  • Pfizer-BioNTech Comirnaty
    • Pfizer-BioNTech Comirnaty containing the original strain (2 formulations: for ages 5 to 11 years and 12 and older)
    • Pfizer-BioNTech Comirnaty Bivalent Original and Omicron BA.4/BA.5 (ages 6 months to 4 years)

2-dose vaccines

  • Pfizer-BioNTech Comirnaty
    • Pfizer-BioNTech Comirnaty containing the original strain (2 formulations: ages 5 to 11 years and ages 12 and older)
    • Pfizer-BioNTech Comirnaty Bivalent Original and Omicron BA.4/BA.5 (ages 5 and older)
  • Moderna Spikevax
    • Moderna Spikevax containing the original strain (3 formulations: ages 6 months to 5 years, ages 6 to 11 years, and ages 12 and older)
    • Moderna Spikevax Omicron XBB.1.5 (ages 6 months to 4 years)
  • AstraZeneca Vaxzevria (ages 18 and older)
  • Novavax Nuvaxovid (ages 18 and older)

1-dose vaccine

Vaccines currently authorized for use as booster doses in Canada include:

  • Pfizer-BioNTech Comirnaty
    • Pfizer-BioNTech Comirnaty containing the original strain (2 formulations: for ages 5 to 11 years and 12 and older)
    • Pfizer-BioNTech Comirnaty Bivalent:
      • Original and Omicron BA.4/BA.5 (ages 5 and older)
      • Original and Omicron BA.1 (ages 12 and older)
  • Moderna Spikevax
    • Moderna Spikevax containing the original strain (ages 18 and older)
    • Moderna Spikevax Bivalent:
      • Original and Omicron BA.4/BA.5 (ages 18 and older)
      • Original and Omicron BA.1 (ages 6 and older)
    • Moderna Spikevax Omicron XBB.1.5 (6 months and older)
  • Novavax Nuvaxovid (ages 18 and older)

Vaccination status definitions

Primary series

In this report, people have ‘completed the primary series’ (referred as ‘fully vaccinated’ in previous reports) once they’ve received all vaccine doses in the series. The number of doses depends on the specific vaccine product. Booster doses are not part of the primary series.

For 3-dose vaccine (Pfizer-BioNTech Comirnaty ages 6 months to 4 years):
  • people who have had only 1 or 2 doses are partially vaccinated
  • people who have had 3 doses have completed their primary vaccine series
For 2-dose vaccines:
  • people who have had only 1 dose are partially vaccinated.
  • people who have had both doses have completed their primary vaccine series (referred to as ‘fully vaccinated’ in previous reports).
  • moderately to severely immunocompromised people who have had both doses plus additional dose of an mRNA vaccine have completed their primary vaccine series.
For 1-dose vaccine (Janssen Jcovden):
  • people who have had only 1 dose have completed their primary vaccine series.
  • moderately to severely immunocompromised people who have had 1 dose plus additional dose of an mRNA vaccine have completed their primary vaccine series.

Booster doses

Doses after the primary series is completed are defined as ‘booster doses’ in this report (referred to as ‘additional doses’ in previous reports). Please note that this category may include doses given for the following reasons:

  • as a booster dose
  • to complete a primary series (for moderately to severely immunocompromised people)
  • for travel purposes
  • to complete a series where the recipient only received vaccines not approved by Health Canada

As the COVID-19 vaccination program evolved over time, some people have received multiple booster doses. People 5 months and older may have received at least 1 booster dose. People at risk of severe illness from COVID-19 may have received up to 3 booster doses.

Local information

For local vaccination coverage data, please see your province’s or territory’s COVID-19 vaccination website.

National vaccination coverage Access and download the national vaccination coverage data over time in .csv format

Vaccination coverage is high in Canada, with [prop_atleast1dose] of the population vaccinated with at least 1 dose.

Figure 1. of who have received of a COVID-19 vaccine in Canada by jurisdiction, MMM DD, YYYY

Hover over or select a portion of the map to see the cumulative number or percent of people vaccinated in Canada and each jurisdiction over time.

The {{Cumulative number of people / Cumulative percent of the population}} who have received at least 1 dose of a COVID-19 vaccine in Canada was {1 000 / 0.1%} as of MMM DD, YYYY.
Access and download the national vaccination coverage data over time in .csv format

For local vaccination coverage data, please see your province’s or territory’s COVID-19 vaccination website.

Cumulative number and percent of people who have received a COVID-19 vaccine in Canada by vaccination status and jurisdiction, MMM DD, YYYY

Figure 1: Text description
Week ending Jurisdiction Age group Cumulative number of people who have received at least 1 dose Cumulative number of people who have completed the primary series Cumulative percent of people who have received at least 1 dose Cumulative percent of people who have completed the primary series

Vaccination coverage by age, sex, and province or territory

For more information on the vaccination status listed in Table 1 and 2, please refer to the Vaccination coverage: Definitions.

Table 1. Cumulative number and percent of people in Canada who have received a COVID-19 vaccine by sex and vaccination status, MMM DD, YYYY

Sex At least 1 dose Primary series completed
Females () ()
Males () ()

Table 2. Cumulative number and percent of people in Canada who have received a COVID-19 vaccine by age group and vaccination status, MMM DD, YYYY

Age group (years) At least 1 dose Primary series completed
Notes

Figure 2. of people who have received of a COVID-19 vaccine in by age group and sex, MMM DD, YYYY Access and download the vaccination coverage by age, sex, and province/territory data over time in .csv format

Hover over or select a bar to see the cumulative number or percent of people vaccinated so far.

Figure 2: Text description

Cumulative number and percent of people who have received a COVID-19 vaccine in Canada by vaccination status, age group, sex, and jurisdiction, MMM DD, YYYY

Jurisdiction Sex Age group Cumulative number of people who have received at least 1 dose Cumulative number of people who have completed the primary series Cumulative percent of people who have received at least 1 dose Cumulative percent of people who have completed the primary series

Figure 3. of who have received of a COVID-19 vaccine in by age group and report week, MMM DD, YYYY Access and download the vaccination coverage by age, sex, and province/territory data over time in .csv format

Hover over or select a portion of the line graph to see the cumulative number or percent of people vaccinated by age group and report week. Click on a legend element to add or remove the corresponding lines from the graph.

Cumulative number and percent of people who have received a COVID-19 vaccine in Canada by vaccination status, age group, sex, and jurisdiction, MMM DD, YYYY

Figure 3: Text description
Week ending Jurisdiction Sex Age group Cumulative number of people who have received at least 1 dose Cumulative number of people who have completed the primary series Cumulative percent of people who have received at least 1 dose Cumulative percent of people who have completed the primary series

Last booster dose by vaccine

Figure 4 shows the breakdown of the number of people that received at least 1 booster dose by last vaccine product received. It is also expressed as a percent relative to the number of people that have completed their primary series.

Most people received the Pfizer-BioNTech Comirnaty vaccine as their last booster dose, followed by the Pfizer-BioNTech Comirnaty Bivalent (Original and Omicron BA.4/BA.5 or BA.1) vaccines.

Figure 4. of people 5 years and older who have received booster doses of a COVID-19 vaccine among those who completed a primary series in by last vaccine product received, MMM DD, YYYY Access and download the cumulative number and percent of people 5 years and older who have received a COVID-19 vaccine among those who completed a primary series by last vaccine product received data in .csv format

Figure 4: Text description

Cumulative number and percent of people who have received a COVID-19 vaccine among those who completed a primary series by last vaccine product received, jurisdiction, and report week, MMM DD, YYYY

Week ending Jurisdiction Vaccine Cumulative number of people who have received a booster dose Cumulative percent of people who have received a booster dose among those who completed the primary series

Additional COVID-19 data resources

Download vaccination coverage data dictionary (.csv)

Acknowledgements

This report would not be possible without the collaboration of provincial and territorial public health partners as well as members of the Pan-Canadian Public Health Network’s Canadian Immunization Registries and Coverage Network (CIRC). We would like to thank everyone taking part in the COVID-19 vaccination rollout in Canada.

Suggested citation

Public Health Agency of Canada. Canadian COVID-19 vaccination coverage report. Ottawa: Public Health Agency of Canada; January 22, 2021. https://health-infobase.canada.ca/covid-19/vaccination-coverage/

Related links

Additional information on inequalities in COVID-19 vaccine uptake and vaccination intent

For health professionals

Top of page

You might also be interested in

COVID-19 epidemiology update

Detailed data about the spread of virus over time.

COVID-19 wastewater surveillance dashboard

Trend data about the levels of COVID-19 in the wastewater.

All Health Infobase data products

Did you find what you were looking for?

What was wrong?

Answers to frequently asked questions can be found in the Understanding the data section!

(Don’t include any personal information. Note that you will not receive a reply.)
Maximum 300 characters

Thank you for your feedback

Date modified: